Erythema Multiforme and Epidermal Necrolysis following COVID-19 Vaccines: A Systematic Review
Dermatitis® · 2025
DOI: 10.1089/derm.2023.0210 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Dermatitis®, 2025. Verfasst von Po-Chien Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taiwan. Hauptthemen laut MEDLINE: Erythema Multiforme, Stevens-Johnson Syndrome, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
The outbreak of COVID-19 pandemic has raised urgent vaccine development to prevent viral transmission. Cutaneous adverse events such as erythema multiforme (EM), Stevens–Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have been observed following COVID-19 vaccination. In this systematic review, we aimed to investigate the clinical features and outcomes of EM/SJS/TEN following COVID-19 vaccination. A comprehensive literature search was conducted in PubMed, Embase, Web of Science, and Cochrane databases up to July 3, 2022. We included studies reporting patients who developed EM, SJS, or TEN following COVID-19 vaccination. A total of 47 studies involving 90 patients with EM and 16 patients with SJS/TEN were reviewed and outlined. EM predominantly occurred after the messenger ribonucleic acid vaccines (70.4%), mostly after the first (47.5%) and second doses (42.4%), with delayed onsets ranging from 1 day to 30 days. SJS/TEN were observed following either the first (55.6%)- or second-dose (33.3%) vaccination, with onset times ranging from 6 hours to 14 weeks. Three EM cases and 1 SJS case showed recurrence upon reexposure to the same vaccines. No mortality was reported. Most patients exhibited improvement or resolution after treatment, with resolution times ranging from 6 days to 8 weeks. In conclusion, EM and epidermal necrolysis, including SJS and TEN, have emerged as potential cutaneous adverse events following COVID-19 vaccine administration. Further research is warranted to elucidate the pathogenesis and casual relationship between COVID-19 vaccines and EM/SJS/TEN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taiwan.
- Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan.
- Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan.
- Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan, Taiwan.
ORCID-Profile: Po-Chien Wu, I-Hsin Huang
Zitieren
APA
Wu, P. C., Huang, I. H., Wang, C. W., Chung, W. H., & Chen, C. B. (2025). Erythema Multiforme and Epidermal Necrolysis following COVID-19 Vaccines: A Systematic Review. Dermatitis®. https://doi.org/10.1089/derm.2023.0210
Vancouver
Wu PC, Huang IH, Wang CW, Chung WH, Chen CB. Erythema Multiforme and Epidermal Necrolysis following COVID-19 Vaccines: A Systematic Review. Dermatitis®. 2025. doi:10.1089/derm.2023.0210
BibTeX
@article{Wu2025,
author = {Wu, Po-Chien and Huang, I-Hsin and Wang, Chuang-Wei and Chung, Wen-Hung and Chen, Chun-Bing},
title = {Erythema Multiforme and Epidermal Necrolysis following COVID-19 Vaccines: A Systematic Review},
journal = {Dermatitis®},
year = {2025},
doi = {10.1089/derm.2023.0210}
}
EUVIMED